New Energy Minerals (ASX:NXE)
The ruby market has continued to grow from strength to strength over the last eight years with prices increasing more than 60%.
This has opened the door for the likes of Mustang Resources (ASX:MUS) an ASX-listed junior explorer looking to capitalise on the rising value of rubies and other in-demand metals.
MUS has a sizeable ruby inventory totalling 333,184 carats and remains the only ASX-listed ruby stock and revenue generating listed ruby developer in the world.
The company has focused on developing its Montepuez Ruby Project, situated in the heart of the globally significant Montepuez gem-field, where it recently uncovered a new ruby-bearing deposit.
MUS has worked hard in 2018 to diversify its interests and has developed a promising portfolio of vanadium and graphite via its high grade Caula Graphite and Vanadium Project in Mozambique.
The Caula Project has a JORC Mineral Resource and has recently returned impressive assay results with grades as high as 1.02% V2O5.
The information on this page should not be the only trigger for your investment decision. Click on the links below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions.
MUS plans to begin initial vanadium and graphite production by mid-2019. This is supported a vanadium price of US$35/kg (up from US$15/kg two years ago) and rising demand for graphite from the growing EV and expandable markets.
2018 looks very promising for this junior explorer with a number of growth catalysts now on the table.
NXE Set to Capitalise on Vanadium Demand as it Fast Tracks Mine Development
Oct 25, 2018
New Energy Minerals (ASX:NXE) is seeking to capitalise on the rising demand for vanadium with a focus on the exploration and mining of the commodity.
Related New Energy Minerals (ASX:NXE) articles
Moto went from 4¢ to $4: This ASX Explorer has Same Backer, Same Country, Same Metal… Same Result?
Aug 16, 2019
One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market
Aug 14, 2019